|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
50
|
|
pubmed:dateCreated |
2005-12-12
|
|
pubmed:abstractText |
Bufexamac is a non-steroidal, anti-inflammatory drug used in the topical treatment of atopic dermatitis, stasis dermatitis and perianal eczema. The substance is known to cause severe allergic contact dermatitis (ACD) as an adverse effect (AE), which may be indistinguishable from the eczema which is to be treated. Hence the diagnosis of this AE is often considerably delayed. In order to estimate the quantitative importance of ACD to bufexamac, data of the Information Network of (German) Departments of Dermatology (IVDK) from July 1999 to December 2004 were analysed.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0012-0472
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
16
|
|
pubmed:volume |
130
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2881-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16342011-Administration, Topical,
pubmed-meshheading:16342011-Adult,
pubmed-meshheading:16342011-Anti-Inflammatory Agents,
pubmed-meshheading:16342011-Bufexamac,
pubmed-meshheading:16342011-Cross-Sectional Studies,
pubmed-meshheading:16342011-Dermatitis, Allergic Contact,
pubmed-meshheading:16342011-Dermatitis, Atopic,
pubmed-meshheading:16342011-Dermatology,
pubmed-meshheading:16342011-Drug Eruptions,
pubmed-meshheading:16342011-Female,
pubmed-meshheading:16342011-Germany,
pubmed-meshheading:16342011-Hospital Departments,
pubmed-meshheading:16342011-Humans,
pubmed-meshheading:16342011-Information Services,
pubmed-meshheading:16342011-Male,
pubmed-meshheading:16342011-Middle Aged,
pubmed-meshheading:16342011-Patch Tests,
pubmed-meshheading:16342011-Poisson Distribution,
pubmed-meshheading:16342011-Risk Factors,
pubmed-meshheading:16342011-Statistics as Topic,
pubmed-meshheading:16342011-Topography, Medical
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
[A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
|
|
pubmed:affiliation |
Zentrale des IVDK, Institut an der Universität Göttingen, Göttingen. aschnuch@med.uni-goettingen.de
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
